“…In conducting an analysis of the previous case reports, we found some patients’ NMOSD and PRES to have had simultaneous onsets of attack and lacked inducing factors in the prodromal stage [ 3 , 7 , 12 ]. Additionally, the asymmetric distribution, atypical location, and non-regression of some PRES lesions [ 3 , 5 , 7 , 10 , 12 ] all suggest that PRES may be a special manifestation of NMOSD. On the contrary, definite inducing factors and characteristic lesions support PRES as a complication of immunotherapy in the treatment of NMOSD [ 3 , 4 , 6 , 9 ].…”